Although the upstream pathway of AKT is frequently activated in cancer cells, owing to receptor and PI3K activation or PTEN inactivation, PHLPP1 suppresses AKT signaling by specific dephosphorylation of AKT Ser473 [10,13,14,15,16]. Here, PTEN is linked to cancer.